Agios Pharmaceuticals (AGIO) Other Gross PP&E Adjustments: 2012-2025
Historic Other Gross PP&E Adjustments for Agios Pharmaceuticals (AGIO) over the last 11 years, with Sep 2025 value amounting to -$33.6 million.
- Agios Pharmaceuticals' Other Gross PP&E Adjustments rose 26.59% to -$33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$106.1 million, marking a year-over-year increase of 31.09%. This contributed to the annual value of $4.2 million for FY2024, which is 154.22% up from last year.
- According to the latest figures from Q3 2025, Agios Pharmaceuticals' Other Gross PP&E Adjustments is -$33.6 million, which was up 8.52% from -$36.8 million recorded in Q2 2025.
- In the past 5 years, Agios Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $4.2 million during Q4 2024, and its lowest value of -$82.2 million during Q1 2021.
- Its 3-year average for Other Gross PP&E Adjustments is -$40.0 million, with a median of -$45.8 million in 2024.
- Data for Agios Pharmaceuticals' Other Gross PP&E Adjustments shows a peak YoY skyrocketed of 154.22% (in 2024) over the last 5 years.
- Agios Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at -$28.4 million in 2021, then spiked by 35.63% to -$18.3 million in 2022, then surged by 57.66% to -$7.8 million in 2023, then skyrocketed by 154.22% to $4.2 million in 2024, then climbed by 26.59% to -$33.6 million in 2025.
- Its Other Gross PP&E Adjustments was -$33.6 million in Q3 2025, compared to -$36.8 million in Q2 2025 and -$39.9 million in Q1 2025.